Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Torres

Showing results (171-180 of 792) with videos related to

Pageof 80
Sort By:
Expert Review of Anti-Infective Therapy|February 17, 2018
Murepavadin: a new antibiotic class in the pipelineIgnacio Martin-Loeches, Glenn E Dale, Antoni Torres
Current Opinion in Critical Care|August 1, 2018
New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. EuropeIgnacio Martin-Loeches, Alejandro H Rodriguez, Antoni Torres
Current Infectious Disease Reports|March 23, 2012
Relation between chronic obstructive pulmonary disease and antibioticsSalvador Sialer, Liapikou Adamantia, Mónica Guerrero, et al.
Critical Care Medicine|June 19, 2013
The authors replyJoan Daniel Marti, Gianluigi Li Bassi, Antoni Torres
Thorax|July 30, 2015
Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal diseaseAntoni Torres, Francesco Blasi, Nathalie Dartois, et al.
Intensive Care Medicine|June 30, 2022
Ventilator-associated pneumoniaOtavio T Ranzani, Michael S Niederman, Antoni Torres
Expert Review of Respiratory Medicine|July 17, 2018
The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasisRosanel Amaro, Meropi Panagiotaraka, Victoria Alcaraz, et al.
Clinics in Chest Medicine|August 27, 2011
The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumoniaMiquel Ferrer, Rosario Menendez, Rosanel Amaro, et al.
Infectious Disease Clinics of North America|March 11, 2004
Nosocomial pneumonia in immunosuppressed patientsCarlos Agustí, Ana Rañó, Oriol Sibila, et al.
Pulmonary Pharmacology & Therapeutics|November 18, 2005
A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitisFrancesco Blasi, Santiago Ewig, Antoni Torres, et al.
Pageof 80

Showing results (171-180 of 792) with videos related to

Sort By:
Pageof 80
Expert Review of Anti-Infective Therapy|February 17, 2018
Murepavadin: a new antibiotic class in the pipelineIgnacio Martin-Loeches, Glenn E Dale, Antoni Torres
Current Opinion in Critical Care|August 1, 2018
New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. EuropeIgnacio Martin-Loeches, Alejandro H Rodriguez, Antoni Torres
Current Infectious Disease Reports|March 23, 2012
Relation between chronic obstructive pulmonary disease and antibioticsSalvador Sialer, Liapikou Adamantia, Mónica Guerrero, et al.
Critical Care Medicine|June 19, 2013
The authors replyJoan Daniel Marti, Gianluigi Li Bassi, Antoni Torres
Thorax|July 30, 2015
Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal diseaseAntoni Torres, Francesco Blasi, Nathalie Dartois, et al.
Intensive Care Medicine|June 30, 2022
Ventilator-associated pneumoniaOtavio T Ranzani, Michael S Niederman, Antoni Torres
Expert Review of Respiratory Medicine|July 17, 2018
The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasisRosanel Amaro, Meropi Panagiotaraka, Victoria Alcaraz, et al.
Clinics in Chest Medicine|August 27, 2011
The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumoniaMiquel Ferrer, Rosario Menendez, Rosanel Amaro, et al.
Infectious Disease Clinics of North America|March 11, 2004
Nosocomial pneumonia in immunosuppressed patientsCarlos Agustí, Ana Rañó, Oriol Sibila, et al.
Pulmonary Pharmacology & Therapeutics|November 18, 2005
A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitisFrancesco Blasi, Santiago Ewig, Antoni Torres, et al.
Pageof 80